Carlsbad, CA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing precision therapies for ...
CARLSBAD, Calif. - Palisade Bio, Inc. (NASDAQ:PALI), a clinical-stage biopharmaceutical company with a current market capitalization of $160 million, has appointed Sharon Skare, PhD(c) as Vice ...
Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company remains focused on ...
Palisade Bio (PALI) announced the appointment of Sharon Skare as Vice President, Global Head of Clinical Operations. Skare most recently served as Vice President and Global Head of Clinical Operations ...
I’ve been a journalist for 30 years, as a senior editor at W magazine, and for the last 17 years, covering retail and real estate as a senior editor at WWD. I write about luxury boutiques, independent ...
Sydney Simone interviewed Gov. Jeff Landry, First Lady of Louisiana Sharon Landry, and President of FMOLHS E.J. Kuiper on Thursday, Oct. 30. Farm-state Republicans finally reach their breaking point ...
Company remains focused on advancing PALI-2108 in ulcerative colitis and fibrostenotic Crohn’s disease, with Phase 2 IND submission planned for H1 2026 Carlsbad, CA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ...
Bill Gates calls for climate strategy pivot ahead of COP30 Billionaire investor and philanthropist Bill Gates called on world leaders on Tuesday to adapt to extreme weather and focus on improving ...
Alina Sharon is a Chicago-based editor for Medical News Today, Healthline, Healthgrades, and HelloMedicare focusing on health, wellness, and Medicare content. She has a master's degree in journalism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback